Sunday, October 18, 2026

GLOO: Gloo's own filings make the short case

Gloo's $3.25 follow-on, going-concern warning and $28.0 million first-half cash burn frame the short case against its acquisition-driven growth.

GLOO $298M

Guardian Research Oct 16 17 clicks

Oct 16 TPRP $128M

Twenty Years in the Dark

Orphan REITs 5 clicks

Oct 16 BMBL $783M

TSOH Weekly Roundup (10/16/2026)

TSOH Investment Research 12 clicks

From X

@InvestSpecial Aug 31

Dalius - Special Sits on X

I really want to be wrong on $LSTA this time around. It’ll be pretty bad for retail shareholders if, by the end of the day, the offer still hasn’t been lobbed. https://t.co/k99Zo100XP

@stockgutter Aug 31

SG on X

$FIRY update from Israeli court https://t.co/yI5CThILVQ

@stockgutter Aug 31

SG on X

Shitco Yarrow Bioscience $YARW has finally cracked. https://t.co/qk6gptxPhj

@ClarkSquareCap Aug 31 1 click

Clark Square Capital on X

Having Sony Music Entertainment makes it a lot less likely Gungho will attempt a take-under of $GRVY, IMO https://t.co/xvjalTHgN7

@mavix_leon Aug 31

mavix on X

I just published my Portfolio Update for August 2026. It includes: ▫️My current Portfolio & position sizes ▫️Earnings Update about $YSN.DE, $SLYG, $LEAT, $4058 ▫️Recent news & information about $CIRC.MI, $EVVTY, $4058, $SLYG https://t.co/bEmwcymkyy

@stockgutter Aug 31

SG on X

This hypothesis was wrong. We now have earnings from $LX $QFIN $FINV, and they all were terrible noting a late June credit event in the industry. Downtrend has continued, and will end when it ends. https://t.co/X86cYvTk0h

@InvestSpecial Aug 31

Dalius - Special Sits on X

7/ $RMTI pitch by @MinotLightCap Potential $18–30/share vs ~$8. Rockwell supplies dialysis concentrates in an effective US duopoly and has finally turned FCF positive. At entry, ~$15m of net cash backed a ~$30m market cap, leaving the operating business valued at ~$15m.

@InvestSpecial Aug 31

Dalius - Special Sits on X

$RMTI management targets ~$100m of revenue by 2030, potentially supporting $5-10m of FCF. Years of losses and a reverse split have left investors skeptical. Still illiquid and operationally fragile, but sustained cash generation could drive a substantial re-rating.

Problems at Dream Finders Homes (DFH)

Dream Finders Homes’ controlling owner borrowed against DFH stock before the homebuilder agreed to finance an acquisition with costly…

DFH $764M

Hunterbrook Oct 15 14 clicks

Park Aerospace: The Q2'27 Sell-Off Misreads a Sole-Source Defense Supplier

Park Aerospace’s 11% Q2’27 sell-off overlooks sole-source PAC-3 rocket-motor materials and A320neo engine composites, with missile capacity…

PKE $571M

Monte Independent Investment Research Oct 15 14 clicks

flyExclusive: Sell Despite Strong Turnaround

FlyExclusive posted 22% Q2 revenue growth and a 20.4% gross margin, but negative free cash flow, net debt and preferred capital leave…

FLYX $58M

Dhierin Bechai Oct 15 1 click

Private Equity Prints Multibaggers With This Pattern. No One is Talking About It.

Shenandoah Telecommunications’ Glo Fiber buildout ends this year, and private infrastructure investors’ repeated fiber deals frame a…

SHEN $544M

Phynvesting Oct 14 22 clicks

El Pollo Loco: New York State Of Mind

El Pollo Loco plans 18 to 20 FY26 openings, including 15 franchised New York stores over five years, as asset-light expansion and…

LOCO $499M

Pedro Goulart Oct 14 1 click

SED Energy: The 40% Dividend. Signal or Noise?

SED Energy's proposed Ventura merger projects a 22% to 40% dividend yield, but idle tender barges, debt and repayments materially reduce…

SBDXF $498M

Cannibal Stocks Oct 13 8 clicks

Monte Investments Market Brief Vol. CXXXI

Park Aerospace reported 27% revenue growth and 72% EPS growth, supported by composite materials for Airbus engines and PAC-3 rocket motors.

PKE $571M

Monte Independent Investment Research Oct 13 5 clicks

H&R REIT, an opportunity in a corrupt process

H&R REIT's proposed GO Residential transaction faces investor opposition over rejected $12.50 cash bids, insider benefits and tax…

GONYF $499M

Nugget Capital Partner's Substack Oct 12 2 clicks

Hippo Holdings ($HIPO): The Insurtech That Stopped Chasing Hype and Started Making Money

Hippo’s insurance platform posted 61% premium growth, a 95.8% combined ratio and a fifth profitable quarter as it shifted toward carrier…

HIPO $931M

Substack von Philipp Oct 10 8 clicks

Brazil Potash: Bull Case Is Starting To (Slowly) Bloom

Brazil Potash has secured court support and a power agreement, but financing, dilution and potash-price-sensitive EBITDA remain central…

GRO $125M

Wolf Report Oct 10 4 clicks

FINV · long

Finvolution Group

FinVolution, a China and ASEAN unsecured consumer lender, trades at 4x earnings and 0.5x book value.

FINV $698M

Value Investors Club Jul 20 4 clicks

Femasys: Launch Is Funded. If The Sales Force Delivers, Then The Company Is In Tall Cotton.

Femasys' $30 million PIPE funds its fertility and birth-control launch, with upside tied to OB/GYN sales execution and health-system wins.

FEMY $14M

Daron Evans Oct 14

Hyster Yale (HY) Multibagger potential as confluence of negatives subside. Attractive after markets part services model

Hyster-Yale trades at 0.16 times sales as lift-truck bookings rebound and restructuring targets $85 million to $100 million in annual…

HY $524M

Calvin Blissett Oct 9 4 clicks

Namib Minerals: Research Note

Namib Minerals posted H1 adjusted EBITDA of $19.0 million, up 76%, as higher gold prices offset lower production.

NAMM $54M

Atrium Research - Equity Research Oct 8 3 clicks

Lesaka: A $4.69 Stock With a $20–30 Case

Lesaka CEO Ali Mazanderani has bought more than $10 million of stock while pursuing a $20 to $30 valuation case through targeted…

LSAK $374M

Mispriced Assets Oct 8 5 clicks

What I’ve Been Up To

Cogent Communications and AI data-center bottlenecks feature in a newsletter update on recruiting, financial media and conference takeaways.

CCOI $428M

Stock Thoughts Oct 7 4 clicks

Lesaka: Why He's Betting Big | Ali Mazanderani | Ep. 5

Lesaka’s executive chairman has invested more than $10 million personally and targets EPS compounding above 40% through consumer, merchant…

LSAK $374M

Mispriced Assets Oct 7 2 clicks

MGP Ingredients (MGPI) - The Hangover After the Whiskey Boom

MGP Ingredients trades at 0.74 times tangible book after whiskey oversupply drove sales declines and more than $400 million of impairments.

MGPI $322M

Dismissed & Asset-Backed Oct 6 1 click

DMRC: 31 retailers in line, up from one

Digimarc’s gift-card watermark pilot found zero fraud at Schnucks, while its retailer pipeline rose to 31 from one in 2025 despite…

DMRC $181M

Trade Ideas Flow Oct 5

Nyxoah: Label Expansion Set To Unlock A Monopoly In A Billion Dollar Market.

Nyxoah's Genio implant could reach CCC patients after an FDA label expansion, targeting 30% of the obstructive sleep apnea device market by…

NYXH $112M

Stephen Tobin Oct 5 3 clicks

Sunday, October 18, 2026

Dalius - Special Sits on X

SG on X

SG on X

Clark Square Capital on X

mavix on X

SG on X

Dalius - Special Sits on X

Dalius - Special Sits on X

Investor Letters

Publications we follow

Newsletters 108

YouTube 4

Blogs 15

Seeking Alpha 52 of 244

X accounts we follow

Investor letters we follow

Sectors